Identifier |
19900204_nanos_sciplatform1_06 |
Title |
Treatment of Pseudotumor Cerebri with Digoxin |
Creator |
James A. Goodwin, MD, University of Illinois Hospital |
Subject |
Pseudotumor Cerebri; Digoxin Treatment; Acetazolamide; Transient Visual Obscurations; Idiopathic Intracranial Hypertension |
Description |
Acetazolamide is a carbonic anhydrase inhibitor that reduces cerebrospinal fluid (CSF) production by about 50% (Maren 1972, McCarthy & Reed 1974) and lowers intracranial pressure. Acetazolamide commonly achieves long lasting control of transient visual obscurations (1VO), headache and diplopia, all of which are manifestations of intracranial hypertension, even though papilledema does not completely resolve. The effect of acetazolamide on intracranial pressure has been shown to be unsustained (Plum & Slesjo 1975), and many patients develop side effects sufficiently severe that compliance is hindered. |
Relation is Part of |
NANOS 1990: Scientific Platform Presentations (Session 1) |
Contributor Primary |
Corbett, James J |
Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
Date |
1990-02-04 |
Type |
Text |
Format |
application/pdf |
Format Creation |
application/pdf |
Source |
1990 North American Neuro-Ophthalmology Society Annual Meeting |
Rights Management |
Copyright 2010. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
Language |
eng |
ARK |
ark:/87278/s6p58v4m |
Setname |
ehsl_novel_nam |
Date Created |
2013-11-05 |
Date Modified |
2021-05-06 |
ID |
183143 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6p58v4m |